- Home
- ATOS vs SFBC Comparison
ATOS vs SFBC Comparison
Compare ATOS & SFBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- SFBC
- Stock Information
- Founded
- ATOS 2009
- SFBC 1953
- Country
- ATOS United States
- SFBC United States
- Employees
- ATOS N/A
- SFBC N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- SFBC Savings Institutions
- Sector
- ATOS Health Care
- SFBC Finance
- Exchange
- ATOS Nasdaq
- SFBC Nasdaq
- Market Cap
- ATOS 112.5M
- SFBC 127.6M
- IPO Year
- ATOS 2012
- SFBC N/A
- Fundamental
- Price
- ATOS $0.86
- SFBC $49.21
- Analyst Decision
- ATOS Strong Buy
- SFBC
- Analyst Count
- ATOS 4
- SFBC 0
- Target Price
- ATOS $6.17
- SFBC N/A
- AVG Volume (30 Days)
- ATOS 668.8K
- SFBC 4.3K
- Earning Date
- ATOS 05-13-2025
- SFBC 07-28-2025
- Dividend Yield
- ATOS N/A
- SFBC 1.53%
- EPS Growth
- ATOS N/A
- SFBC N/A
- EPS
- ATOS N/A
- SFBC 1.95
- Revenue
- ATOS N/A
- SFBC $36,560,000.00
- Revenue This Year
- ATOS N/A
- SFBC N/A
- Revenue Next Year
- ATOS N/A
- SFBC N/A
- P/E Ratio
- ATOS N/A
- SFBC $25.34
- Revenue Growth
- ATOS N/A
- SFBC N/A
- 52 Week Low
- ATOS $0.55
- SFBC $39.72
- 52 Week High
- ATOS $1.66
- SFBC $55.99
- Technical
- Relative Strength Index (RSI)
- ATOS 51.39
- SFBC 36.33
- Support Level
- ATOS $0.84
- SFBC $48.50
- Resistance Level
- ATOS $0.93
- SFBC $50.49
- Average True Range (ATR)
- ATOS 0.06
- SFBC 0.54
- MACD
- ATOS -0.00
- SFBC -0.08
- Stochastic Oscillator
- ATOS 66.40
- SFBC 32.19
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About SFBC Sound Financial Bancorp Inc.
Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.